IL1B and neoplasm: While GSDME is traditionally recognized for its pyroptosis-inducing capacity in response to chemotherapeutic agents, in HCC, its tumor-promoting effects manifest through alternative pathways that bypass characteristic pyroptotic cell death markers such as cell swelling, pore formation, and massive IL-1β release.